You are here

Article info

Article menu

Download PDFPDF

Biomarkers of disease
Original article
Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma

Authors

  • Jenette Creaney National Centre for Asbestos Related Diseases, School of Medicine and Pharmacology, University of Western Australia, Nedlands, Western Australia, Australia The Australian Mesothelioma Tissue Bank, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia PubMed articlesGoogle scholar articles
  • Ian M Dick National Centre for Asbestos Related Diseases, School of Medicine and Pharmacology, University of Western Australia, Nedlands, Western Australia, Australia PubMed articlesGoogle scholar articles
  • Tarek M Meniawy National Centre for Asbestos Related Diseases, School of Medicine and Pharmacology, University of Western Australia, Nedlands, Western Australia, Australia PubMed articlesGoogle scholar articles
  • Su Lyn Leong National Centre for Asbestos Related Diseases, School of Medicine and Pharmacology, University of Western Australia, Nedlands, Western Australia, Australia The Australian Mesothelioma Tissue Bank, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia PubMed articlesGoogle scholar articles
  • Justine S Leon National Centre for Asbestos Related Diseases, School of Medicine and Pharmacology, University of Western Australia, Nedlands, Western Australia, Australia The Australian Mesothelioma Tissue Bank, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia PubMed articlesGoogle scholar articles
  • Yvonne Demelker National Centre for Asbestos Related Diseases, School of Medicine and Pharmacology, University of Western Australia, Nedlands, Western Australia, Australia The Australian Mesothelioma Tissue Bank, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia PubMed articlesGoogle scholar articles
  • Amanda Segal PathWest Laboratory Medicine WA, Queen Elizabeth II Medical Centre, Nedlands, Western Australia, Australia PubMed articlesGoogle scholar articles
  • A W (Bill) Musk National Centre for Asbestos Related Diseases, School of Medicine and Pharmacology, University of Western Australia, Nedlands, Western Australia, Australia Department of Respiratory Medicine, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia PubMed articlesGoogle scholar articles
  • Y C Gary Lee Department of Respiratory Medicine, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia Centre for Asthma, Allergy and Respiratory Research, School of Medicine and Pharmacology, University of Western Australia, Nedlands, Western Australia, Australia PubMed articlesGoogle scholar articles
  • Steven J Skates Biostatistics Center, Massachusetts General Hospital, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Anna K Nowak National Centre for Asbestos Related Diseases, School of Medicine and Pharmacology, University of Western Australia, Nedlands, Western Australia, Australia Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia PubMed articlesGoogle scholar articles
  • Bruce W S Robinson National Centre for Asbestos Related Diseases, School of Medicine and Pharmacology, University of Western Australia, Nedlands, Western Australia, Australia The Australian Mesothelioma Tissue Bank, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia Department of Respiratory Medicine, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Jenette Creaney, National Centre for Asbestos Related Diseases, School of Medicine and Pharmacology, University of Western Australia, Nedlands, WA 6009, Australia; jenette.creaney{at}uwa.edu.au
View Full Text

Citation

Creaney J, Dick IM, Meniawy TM, et al
Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma
Thorax 2014;69:895-902.

Publication history

  • Received January 28, 2014
  • Revised June 25, 2014
  • Accepted June 26, 2014
  • First published July 18, 2014.
Online issue publication 
September 01, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/